drugset / Trial / NCT02863575

A Dental Pain Study Comparing The Analgesic Efficacy Of Ibuprofen/Caffeine

NCT02863575

Phase 3 Completed 374 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

An efficacy study assessing analgesic effect of ibuprofen/caffeine in post-surgical dental pain.

Timeline

Start
2017-10-24
Primary completion
2018-04-06
Completion
2018-04-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 100 mg Oral
Comparator Ibuprofen Small molecule 400 mg Oral

Indications

No indication recorded.